BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.nebraska.edu

Clinical Trials

Global Genomic and Proteomic Profiling of African Children With Typhoid Fever

Completed

Conditions: Typhoid Fever

First Posted Date: 2016-10-27

Last Posted Date: 2023-09-29

Lead Sponsor: University of Nebraska

Target Recruit Count: 969

Registration Number: NCT02947295

Locations: 🇳🇬
National Hospital of Nigeria, Abuja, Nigeria

Improving Mobility in Peripheral Artery Disease Using an Ankle Foot Orthosis

Not Applicable

Completed

Conditions: Peripheral Artery Disease

Interventions: Device: Ankle foot orthosis
Other: Control/standard of care

First Posted Date: 2016-09-15

Last Posted Date: 2024-08-20

Lead Sponsor: University of Nebraska

Target Recruit Count: 50

Registration Number: NCT02902211

Locations: 🇺🇸
Omaha VA Medical Center, Omaha, Nebraska, United States
🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

TGR-1202 and Ibrutinib in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Phase 2

Completed

Conditions: Recurrent Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell Lymphoma

Interventions: Drug: Ibrutinib
Other: Laboratory Biomarker Analysis
Drug: PI3K-delta Inhibitor TGR-1202

First Posted Date: 2016-08-22

Last Posted Date: 2023-10-05

Lead Sponsor: University of Nebraska

Target Recruit Count: 13

Registration Number: NCT02874404

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Local Heat-Stress as a Mechanism of Hearing Preservation

Not Applicable

Withdrawn

Conditions: Hearing Loss

Interventions: Device: ICS AirCal3

First Posted Date: 2016-08-19

Last Posted Date: 2023-08-22

Lead Sponsor: University of Nebraska

Registration Number: NCT02872844

Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis

Phase 4

Recruiting

Conditions: Peripheral Arterial Disease

Interventions: Drug: Ramipril

First Posted Date: 2016-07-22

Last Posted Date: 2024-05-09

Lead Sponsor: University of Nebraska

Target Recruit Count: 70

Registration Number: NCT02842424

Locations: 🇺🇸
VA Medical Center, Omaha, Nebraska, United States

Shared Medical Visits for Spanish-speaking Patients With Type 2 Diabetes

Not Applicable

Completed

Conditions: Diabetes Mellitus Type 2

Interventions: Behavioral: Shared Medical Visit

First Posted Date: 2016-07-18

Last Posted Date: 2023-12-28

Lead Sponsor: University of Nebraska

Target Recruit Count: 9

Registration Number: NCT02836015

Locations: 🇺🇸
Nebraska Medicine, Midtown Health Center, Omaha, Nebraska, United States

Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma

Phase 1

Terminated

Conditions: Glioma
Glioblastoma

Interventions: Dietary Supplement: Ascorbic Acid
Biological: Bevacizumab
Other: Laboratory Biomarker Analysis
Other: Quality-of-Life Assessment

First Posted Date: 2016-07-14

Last Posted Date: 2023-10-24

Lead Sponsor: University of Nebraska

Target Recruit Count: 9

Registration Number: NCT02833701

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders

Phase 2

Completed

Conditions: Mood Disorder
Disruptive Behavior Disorders

Interventions: Drug: Placebo
Drug: Oxytocin

First Posted Date: 2016-07-06

Last Posted Date: 2023-10-05

Lead Sponsor: University of Nebraska

Target Recruit Count: 58

Registration Number: NCT02824627

Locations: 🇺🇸
University of Nebraska Medical Center, Department of Psychiatry, Omaha, Nebraska, United States

Multi-modality Localization of Eloquent Brain Function

Withdrawn

Conditions: Brain Neoplasms

First Posted Date: 2016-06-10

Last Posted Date: 2023-08-22

Lead Sponsor: University of Nebraska

Registration Number: NCT02795338

Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery

Completed

Conditions: Myelodysplastic Syndrome
Multiple Myeloma
Chronic Myeloid Leukemia
Non-hodgkin Lymphoma
Acute Lymphoid Leukemia
Acute Myeloid Leukemia
Effects of Chemotherapy
Mild Cognitive Impairment
Chronic Lymphocytic Leukemia

First Posted Date: 2016-05-10

Last Posted Date: 2023-09-29

Lead Sponsor: University of Nebraska

Target Recruit Count: 45

Registration Number: NCT02767388

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy